Jill Marie Broadfoot

Insider Reports History

Location
C/O Atyr Pharma, Inc., 10240 Sorrento Valley Road, Suite 300, San Diego, CA
Signature
/s/ Martha Adler, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jill Marie Broadfoot:

Stock Role Class Num Shares Value Price $ Report Date Ownership
aTYR PHARMA INC Chief Financial Officer Common Stock 31.8K $120K $3.78 Feb 4, 2025 Direct
aTYR PHARMA INC Chief Financial Officer Restricted Stock Unit 3.75K $14.2K $3.78 Feb 3, 2025 Direct
aTYR PHARMA INC Chief Financial Officer Restricted Stock Unit 7.5K $8.84K $1.18 Feb 5, 2024 Direct
TALPHERA, INC. Director Common Stock 8.55K $7.62K $0.89 Oct 23, 2025 Direct
aTYR PHARMA INC Chief Financial Officer Employee Stock Option (right to buy) 275K Jan 8, 2025 Direct
Cue Biopharma, Inc. Director Stock Option (right to buy) 48.8K Jun 4, 2025 Direct
OTONOMY, INC. Director Stock Option (right to buy) 27.5K Jun 21, 2022 Direct
TALPHERA, INC. Director Stock Option (Right to Buy) 25.6K Oct 23, 2025 Direct

Insider Reports Filed by Jill Marie Broadfoot

Symbol Company Period Transactions Value $ Form Type Date Filed Role
TLPH TALPHERA, INC. Oct 23, 2025 2 $0 4 Oct 24, 2025 Director
CUE Cue Biopharma, Inc. Jun 4, 2025 1 $0 4 Jun 6, 2025 Director
CUE Cue Biopharma, Inc. Jun 4, 2025 0 $0 3 Jun 6, 2025 Director
ATYR aTYR PHARMA INC Feb 3, 2025 3 -$4.74K 4 Feb 4, 2025 Chief Financial Officer
ATYR aTYR PHARMA INC Jan 8, 2025 1 $0 4 Jan 10, 2025 Chief Financial Officer
TLPH TALPHERA, INC. Jun 24, 2024 2 $0 4 Jun 24, 2024 Director
LIFE aTYR PHARMA INC May 31, 2024 1 $8.95K 4 Jun 3, 2024 Chief Financial Officer
LIFE aTYR PHARMA INC Feb 5, 2024 3 -$2.69K 4 Feb 6, 2024 Chief Financial Officer
LIFE aTYR PHARMA INC Jan 5, 2024 1 $0 4 Jan 9, 2024 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Oct 10, 2023 2 $0 4 Dec 13, 2023 Director
LIFE aTYR PHARMA INC Feb 16, 2023 1 $0 4 Feb 21, 2023 Chief Financial Officer
LIFE aTYR PHARMA INC Feb 3, 2023 3 -$3.7K 4 Feb 6, 2023 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Jul 15, 2022 2 $0 4 Jul 15, 2022 Director
OTIC OTONOMY, INC. Jun 21, 2022 1 $0 4 Jun 23, 2022 Director
LIFE aTYR PHARMA INC May 24, 2022 1 $0 4 May 26, 2022 Chief Financial Officer
LIFE aTYR PHARMA INC Feb 3, 2022 2 $0 4 Feb 7, 2022 Chief Financial Officer
LIFE aTYR PHARMA INC Jan 13, 2022 1 $13K 4 Jan 18, 2022 Chief Financial Officer
ACRX ACELRX PHARMACEUTICALS INC Nov 20, 2021 2 $0 4 Nov 23, 2021 Director
ACRX ACELRX PHARMACEUTICALS INC Nov 20, 2021 0 $0 3 Nov 23, 2021 Director
OTIC OTONOMY, INC. Aug 18, 2021 1 $0 4 Aug 20, 2021 Director
OTIC OTONOMY, INC. Aug 18, 2021 0 $0 3 Aug 20, 2021 Director
LIFE aTYR PHARMA INC May 21, 2021 1 $0 4 May 25, 2021 Chief Financial Officer